Firms invest further— despite tough environment

Most pharmaceutical fine chemical manufacturers interviewed by CW at CPhI, the largest annual trade fair for the global pharmaceutical ingredients industry, held recently in Madrid, said they were optimistic about the outlook for the sector and planning a range of investments to grow their businesses. Companies believe that the US FDA’s Generic Drug User Fee Act (GDUFA), which became effective on 1 October 2012, will help eliminate from the market manufacturers with unacceptably low levels of quality. Ananthanarayanan: API unit being built. Schmitz: Decided...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers